Home › Compare › CMXC vs O

CMXC vs O: Dividend Comparison 2026

CMXC yields 470.59% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CMXC wins by $38545.08M in total portfolio value
10 years
CMXC
CMXC
● Live price
470.59%
Share price
$0.43
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$38545.12M
Annual income
$27,182,357,871.92
Full CMXC calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.15
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,102.74
Full O calculator →

Portfolio growth — CMXC vs O

📍 CMXC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCMXCO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CMXC + O cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CMXC pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CMXC
Annual income on $10K today (after 15% tax)
$40,000.00/yr
After 10yr DRIP, annual income (after tax)
$23,105,004,191.13/yr
O
Annual income on $10K today (after 15% tax)
$449.12/yr
After 10yr DRIP, annual income (after tax)
$4,337.33/yr
At 15% tax rate, CMXC beats the other by $23,104,999,853.80/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CMXC + O for your $10,000?

CMXC: 50%O: 50%
100% O50/50100% CMXC
Portfolio after 10yr
$19272.58M
Annual income
$13,591,181,487.33/yr
Blended yield
70.52%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

CMXC
No analyst data
Altman Z
-276.8
Piotroski
3/9
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.7% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CMXC buys
0
O buys
0
No recent congressional trades found for CMXC or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCMXCO
Forward yield470.59% ✓5.28%
Annual dividend / share$2.00$3.23 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.1% ✓
Portfolio after 10y$38545.12M ✓$34.2K
Annual income after 10y$27,182,357,871.92 ✓$5,102.74
Total dividends collected$37542.88M ✓$20.7K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: CMXC vs O ($10,000, DRIP)

YearCMXC PortfolioCMXC Income/yrO PortfolioO Income/yrGap
1← crossover$57,759$47,058.82$10,818$608.16+$46.9K → CMXC
2$315,826$254,024.51$11,787$741.68+$304.0K → CMXC
3$1,636,076$1,298,141.44$12,946$911.00+$1.62M → CMXC
4$8,035,425$6,284,824.27$14,345$1,127.94+$8.02M → CMXC
5$37,445,846$28,847,941.19$16,056$1,409.05+$37.43M → CMXC
6$165,706,448$125,639,392.36$18,171$1,777.83+$165.69M → CMXC
7$696,916,266$519,610,366.98$20,820$2,268.21+$696.90M → CMXC
8$2,788,074,169$2,042,373,764.24$24,188$2,929.90+$2788.05M → CMXC
9$10,619,401,952$7,636,162,591.12$28,533$3,837.11+$10619.37M → CMXC
10$38,545,117,961$27,182,357,871.92$34,235$5,102.74+$38545.08M → CMXC

CMXC vs O: Complete Analysis 2026

CMXC — Stock

Cell MedX Corp., a biotech company, focuses on the discovery, development, and commercialization of therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company was formerly known as Sports Asylum, Inc. and changed its name to Cell MedX Corp. in September 2014. Cell MedX Corp. was incorporated in 2010 and is based in Carson City, Nevada.

Full CMXC Calculator →

O — REIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this CMXC vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CMXC vs SCHDCMXC vs JEPICMXC vs KOCMXC vs MAINCMXC vs STAGCMXC vs ADCCMXC vs NNNCMXC vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.